SubscribeElsewhere on HealthThreads: Stomach cancer | Thyroid cancer | Overactive bladder | Lymphoma |
Inventors Develop Novel Technique To Help Customize, Enhance The Effectiveness Of Bladder Cancer Treatment 
Medical News Today | Fri, May 15
Medical News Today is the #2 News Source for Bladder cancer
Researchers in the University of Virginia Department of Urology have developed a novel method that could help physicians determine the best course of treatment for patients suffering from bladder cancer.
Try These Related Topics
More Medical News Today
Outcomes Of Patients Undergoing Radical Cystoprostatectomy For Bladder Cancer With Prostatic Involvement On Final ...
What Is Schistosomiasis (Bilharzia)? What Causes Schistosomiasis (Bilharzia)?
BioCis Pharma Starts A Phase I Clinical Trial With A New Cancer Drug
Bladder Cancer - Molecular Analyte Profiling Of Early Events & Tissue Conditioning Following Intravesical Bacillus ...
Genetic Variants Predict Recurrence Of Bladder Cancer, Patient Survival
Bladder Cancer SNP Panel Predicts Susceptibility And Survival
More Intensive Treatment Not Associated With Better Outcomes In Early Bladder Cancer
Predictive Biosciences Presents Novel Multi-Analyte Approach To Diagnostic ... - Medical News Today
TARIS Successfully Completes Phase 1 Study - Medical News Today
The Use Of Short Tandem Repeat Profiling To Characterize Human Bladder Cancer Cell Lines
FDA Designates Fast Track Status For Apaziquone (EOquin(R)) For Bladder Cancer
The Effect Of On-Line Position Correction On The Dose Distribution In Focal ... - Medical News Today
Related News
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive ...
Spectrum collaborates with Handok to develop & commercialize apaziquone in S Korea
UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drug
Genetic Data Confirm Bladder Cancer Link to Smoking
Intravesical Taxotere® Maintenance Therapy May Improve Treatment of ...
Small cap investors take note of good change for (Nasdaq:SPPI) (Nasdaq:VICL ...
Top Bloggers
Related Photos
Opinion: Indevus Pharmaceuticals: Valstar reintroduced into bladder cancer ...
SYS-CON Media (press release) There is a high unmet need in the treatment of recurrent CIS bladder tumors because, generally, they do not respond well to chemotherapy. BCG immunotherapy shows the best efficacy against recurrent CIS bladder tumors, but patients often show poor ...
Thu, Mar 19 | from drugdiscovery.pharmaceutical-business-review.com
